印醇-3-酸在偏头痛病理生理学中的神经保护作用
Dilek Agircan1, Seyhan Taskin2, Murat Cekic1
1Department of Neurology, Harran Faculty of Medicine, Harran University, Sanliurfa 63290, Turkey.
Medicina (Kaunas, Lithuania)
|September 28, 2024
概括
印度尔-3-酸 (IPA) 通过减少化应激应激,可以预防偏头痛. 在偶发性偏头痛患者中,较高的IPA水平与较少的发作相关,这表明治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 病理生理学 病理生理学
背景情况:
- 偏头痛是全球残疾的主要原因之一.
- 病理生理学涉及氧化和化应激.
- 印-3-酸 (IPA) 显示出潜在的神经保护作用.
研究的目的:
- 研究IPA和化压力生物标志物在偏头痛中的作用.
- 探索它们作为偏头痛治疗点的潜力.
主要方法:
- 横截面的病例控制研究,包括57名偏头痛患者和30名对照人群.
- 测量了IPA,氧化 (NO),氧化合成酶 (NOS) 和过氧化 (ONOO-) 的血清水平.
- 使用经过验证的偏头痛严重程度和生活质量等级.
主要成果:
- 偏头痛患者与对照人群相比,血清IPA和NO水平存在显著差异.
- 在情节性偏头痛 (EM) 中IPA水平较高,在慢性偏头痛 (CM) 中NO水平较高.
- 增加的NO与增加的发作频率和严重程度相关;IPA显示出负相关性.
结论:
- IPA和化压力在偏头痛病理生理学中起着重要作用.
- 在EM中升高的IPA表明潜在的神经保护作用.
- 针对氧化和化应激路径可能产生有效的偏头痛疗法.
相关概念视频
Pathophysiology of Vomiting
333
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
333
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
152
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
152
Analgesia and Pain Management
547
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
547
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


